Académique Documents
Professionnel Documents
Culture Documents
Chemical Strategies Used in Studying ProteinProtein Interactions and DNA-Protein Interactions Examples
Cleaved by hOGG1
oxoG is misread to T (thymine) during replication of DNA. The resulting oxoG T mispair in another round of replication is mutated to T A. Only 50,000 molecules of hOGG1 protect the entire 6x10^9 base-pair nuclear genomic. Banerjee et al. Nature, 2005, 434, 612
Structural Studies have revealed that oxoG nucleoside is completely extruded from the DNA duplex, and inserted deeply into a lesion recognition pocket.
Catalytic site G0 C
G0 C
G0 C
Is this single interaction enough to distinguish the oxoG from G? One H-B is equivalent of 1.5-3 kcal/mol.
Solution of Verdines group (Harvard) in addressing the issue of how hOGG1 is able to discriminate between oxoG and G
Strategy: Comparing the structure of hOGG1 bound to DNA presenting an oxoG lesion site to that of the enzyme bound to DNA presenting the normal base G, and use them as a basis for free energy difference calculations. The problem: the hOGG1:DNA(G) failed to form. Solution: Forcing the DNA(G) and the protein to form a stable complex by implanting a disulfide crosslink into the interface between the protein and DNA
Disulfide-Crosslinking Strategy
Disulfide-Crosslinking Strategy
oxoG complex
G complex
The free energy calculation indicated that there is indeed a stabilization effect coming from the H-B formed between Gly(C=O) and the N7H, worth of 3.5 kcal/mol
Protein-protein interaction are a central regulatory feature to nearly all biological processes in a living organism. They have been a target either for development of novel chemotherapeutic treatments or for understanding protein function. Peptides have been an important strategy to target proteinprotein interaction, through mimicking these interactions.
Peptide-based therapeutics are limited to: 1) Low bioavailability; 2) Inefficiency in crossing cell membranes (due to their size); 3) Poor metabolic stability in vivo. Peptidomimetics contain nonnatural amino acids. They mimic the structural and functional properties of their native parental peptides. They often are more stable in vivo, and an increased ability to penetrate cell membranes.
Peptides and peptidomimetics have been used quite often to target vital biological processes in cancer cells, as protein-protein interactions play an important role in the biology of cancer. For example, Apoptosis (programmed cell death) is important in preventing the cells to become carcinogenic, escape from this mechanism correlates with tumor aggressiveness and resistance to anticancer drug treatments.
Bax, (cytoplasmic) and Bak (within mitochondria) are inducers of apoptosis. They are multipledomains and contain a domain known as BH3, an all helical domain. Bid is a proapoptotic protein that contain only BH3 domain that interacts with Bax and Bak causing their oligomerization.
An effective mechanism of inducing apoptosis is to cause oligomerization of the proapoptotic proteins such as Bak and Bax.
Strategy: design a peptidomimetic, well-folded ligand, that mimics interaction of BH3 with Bax and Bak.
Verdines Group: Used a technique called hydrocarbon stapling to generated a staple that stabilized the -helical structure of BH3 peptide
Non-natural AA BH3 Stabilized -helix
Has been used in synthesizing proteins Design of novel tertiary structures Glycosylation of proteins
Synthetic strategy
Synthesis of glycoproteins Glycosylation enhances the stability of the peptides and proteins in vivo. It enhances the blood-brain barrier, reduce the susceptibility to proteases. It is very difficult to incorporate glycosylation into peptides and protein produced in bacteria.